The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B
Open accessAbstract
We have studied mechanisms controlling activation of the gelatinase B gene (matrix metalloproteinase-9) by fibroblast growth factor-2 (FGF-2) during angiogenesis, and the effects of the natural product curcuminoids on this process. Using a transgenic mouse (line 3445) harboring a gelatinase B promoter/lacZ fusion gene, we demonstrate FGF-2 stimulation of reporter gene expression in endothelial cells of invading neocapillaries in the corneal micropocket assay. Using cultured corneal cells, we show that FGF-2 stimulates DNA binding activity of transcription factor AP-1 but not NF-kappaB and that AP-1 stimulation is inhibited by curcuminoids. We further show that induction of gelatinase B transcriptional promoter activity in response to FGF-2 is dependent on AP-1 but not NF-kappaB response elements and that promoter activity is also inhibited by curcuminoids. In rabbit corneas, the angiogenic response induced by implantation of an FGF-2 pellet is inhibited by the co-implantation of a curcuminoid pellet, and this correlates with inhibition of endogenous gelatinase B expression induced by FGF-2. Angiostatic efficacy in the cornea is also observed when curcuminoids are provided to mice in the diet. Our findings provide evidence that curcuminoids target the FGF-2 angiogenic signaling pathway and inhibit expression of gelatinase B in the angiogenic process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Schreck, R., Albermann, K., & Baeuerle, P. A. (1992) · Free Radical Research Communications · doi:10.3109/10715769209079515 · Cited by 1,401
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Angiogenesis inhibited by drinking tea
Cao, Y., & Cao, R. (1999) · Nature · doi:10.1038/18793 · Cited by 688
Cited by
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Multiple biological activities of curcumin: A short review
Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.007 · Cited by 1,674
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,066
Matrix metalloproteinases and angiogenesis
Rundhaug, J. E. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00355.x · Cited by 960
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771546 · Cited by 946
Bharti, A. C., Donato, N., Singh, S., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2002-05-1320 · Cited by 685
Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials
Strimpakos, A. S., & Sharma, R. A. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1769 · Cited by 645
Asahi, M., Asahi, K., Jung, J.-C., del Zoppo, G. J., Fini, M. E., & Lo, E. H. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00007 · Cited by 610
Self-citation“Spicing Up” of the Immune System by Curcumin
Jagetia, G. C., & Aggarwal, B. B. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9066-7 · Cited by 610
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
Folgueras, A. R., Pendas, A. M., Sanchez, L. M., & Lopez-Otin, C. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041811af · Cited by 590
Kunnumakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., & Aggarwal, B. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4257 · Cited by 578
Chang, J.-H., Gabison, E. E., Kato, T., & Azar, D. T. (2001) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200108000-00002 · Cited by 546
Hong, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh165 · Cited by 432
Anto, R. J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.143 · Cited by 429
Role of Curcumin in Cancer Therapy
Shishodia, S., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2007.04.001 · Cited by 413
MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology
Sivak, J. M., & Fini, M. E. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00015-5 · Cited by 404
Self-citationLópez-Lázaro, M. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700238 · Cited by 389
Withaferin A is a potent inhibitor of angiogenesis
Mohan, R., Hammers, H., Bargagna-mohan, P., Zhan, X., Herbstritt, C., Ruiz, A., Zhang, L., Hanson, A., Conner, B., Rougas, J., et al. (2004) · Angiogenesis · doi:10.1007/s10456-004-1026-3 · Cited by 382
Self-citationAnti cancer effects of curcumin: cycle of life and death
Sa, G., & Das, T. (2008) · Cell Division · doi:10.1186/1747-1028-3-14 · Cited by 382
Wang, X., Jung, J., Asahi, M., Chwang, W., Russo, L., Moskowitz, M. A., Dixon, C. E., Fini, M. E., & Lo, E. H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-07037.2000 · Cited by 371
Self-citationCurcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects
Hassan, F.-U., Rehman, M. S.-U., Khan, M. S., Ali, M. A., Javed, A., Nawaz, A., & Yang, C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00514 · Cited by 357
A Review of Therapeutic Effects of Curcumin
Noorafshan, A., & Ashkani-Esfahani, S. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289273 · Cited by 317
Curcumin exerts multiple suppressive effects on human breast carcinoma cells
Shao, Z., Shen, Z., Liu, C., Sartippour, M. R., Go, V. L., Heber, D., & Nguyen, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10183 · Cited by 313
Kim, G.-Y., Kim, K.-H., Lee, S.-H., Yoon, M.-S., Lee, H.-J., Moon, D.-O., Lee, C.-M., Ahn, S.-C., Park, Y. C., & Park, Y.-M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8116 · Cited by 306
Chen, A., Xu, J., & Johnson, A. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209019 · Cited by 301
Shishodia, S., Potdar, P., Gairola, C. G., & Aggarwal, B. B. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg078 · Cited by 292
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
Turpeenniemi-Hujanen, T. (2005) · Biochimie · doi:10.1016/j.biochi.2005.01.014 · Cited by 289
Angiogenesis in Endocrine Tumors
Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0008 · Cited by 275
Aggarwal, S., Takada, Y., Singh, S., Myers, J. N., & Aggarwal, B. B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20333 · Cited by 274
Bauvois, B., & Dauzonne, D. (2006) · Medicinal Research Reviews · doi:10.1002/med.20044 · Cited by 266
Molecular mechanisms of curcumin action: Gene expression
Shishodia, S. (2013) · BioFactors · doi:10.1002/biof.1041 · Cited by 263
Molecular mechanisms of anti-angiogenic effect of curcumin
Gururaj, A. E., Belakavadi, M., Venkatesh, D. A., Marmé, D., & Salimath, B. P. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02306-9 · Cited by 253
Metadata
- Authors
- Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B., & Fini, M. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 275
- Issue
- 14
- Pages
- 10405-10412
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2048635128
- Cited by
- 274
- References
- 48
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.